The securities of Arovella Therapeutics Limited (‘ALA’) will be placed in trading halt at the request of ALA, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Wednesday, 11 October 2023 or when the announcement is released to the market.
Scarlette de Lavaine
Adviser, Listings Compliance
For more information, download the attached PDF.
Download this document